VirTra, Inc. (VTSI) reported fourth‑quarter and full‑year 2025 financial results that fell short of analyst expectations. Total revenue for the year ended December 31, 2025, was $22.4 million, a 15% decline from $26.4 million in 2024, while net income dropped to $0.3 million, or $0.02 per diluted share, compared with $1.4 million ($0.12 per share) in 2024. Backlog grew to $25.6 million, giving the company a sizable pipeline as it anticipates a rebound when federal funding cycles normalize.
In the fourth quarter, revenue was $2.9 million, down 38.3% from $4.7 million in the same period last year. Gross profit was $1.7 million, or 58% of revenue, a compression from 62% year‑ago, driven by lower revenue volume and a shift in product mix. Operating expenses fell 23% to $3.3 million, reflecting disciplined cost management, yet the company posted a net loss of $1.0 million, or $0.09 per diluted share, a miss of $0.07 per share versus the consensus estimate of a $0.02 to $0.03 loss.
The revenue shortfall was largely attributable to delayed federal funding and the timing of customer procurement cycles. While international revenue grew 35.5% year‑over‑year, the government segment declined 22.3%, underscoring the impact of funding delays. Margin compression was also driven by a higher mix of lower‑margin accessories and increased cost of goods sold, offsetting the benefit of cost‑control measures that reduced operating expenses.
"Our disciplined financial approach has allowed us to preserve flexibility with a strong balance sheet. We are moving through 2026 with a clearer operational runway, and as funding conditions continue to normalize, our focus remains on converting backlog and pipeline activity into revenue," said CEO John Givens. CFO Alanna Boudreau added, "Our total revenue for the fourth quarter was $2.9 million, compared to $4.7 million in the prior year period. The decrease was driven by those continued delays in government funding, the timing of customer procurement cycles, and deferred deliveries across both domestic and international customers." She also noted that net operating expense for the year was $14.8 million, down 15% from $17.4 million in 2024, reflecting active cost management while investing in key growth areas.
The market reacted negatively, with VirTra’s stock falling between 4.87% and 7% in aftermarket trading following the announcement. The decline reflected investors’ disappointment over the significant miss on both revenue and earnings per share, as the company’s results fell well below analyst consensus estimates.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.